Summit-based Concord Health Partners, a health care focused investment firm, Thursday announced that Robert Schulz has joined as managing director.
Schulz will report directly to James Olsen, founder and managing partner at Concord, and support the firm’s investment activities, including sourcing and executing on portfolio company acquisitions and supporting platform investments.
Schulz joins Concord with over 25 years of health care private equity experience, in addition to 13 years in investment banking and general venture capital. Most recently, he served as co-founder of CB Health Ventures and Health Enterprise Partners, which were established in 1997 and 2006, respectively. Previously, Schulz served as president and chief operating officer of Harris & Harris Group, a publicly traded investment firm, and spent 10 years as an investment banker at the First Boston Corp.
“Bob brings a wealth of experience in health care investing, with deep industry knowledge and a long, successful track record. We are thrilled to add him to the Concord team,” Olsen stated. “His joining the firm is another exciting step in our continued growth and evolution, and further strengthens our investment team to better identify and execute on compelling investment opportunities. We established Concord to create value through long-term strategic partnerships with (limited partnerships) and portfolio companies, and adding Bob enhances our ability to execute on that strategy. I look forward to working with him and the rest of our team to drive adoption and growth of innovative technologies and solutions that reduce costs, increase access and improve quality of care.”
“Concord’s unique approach and leading health care LP base have uniquely positioned the firm as a value-add strategic partner to its portfolio companies,” Schulz said. “In my more than two decades of investing in health care, the ability to work collaboratively with both portfolio companies and LPs has never been more critical. James and the Concord team have established an incredible track record of doing just that to drive growth across its portfolio, and I look forward to helping the firm continue its evolution as a leading investment platform in the health care space.”
As announced Monday, the firm recently closed the Concord Innovation Fund II with $150 million in committed capital, representing a 300% increase from the firm’s first investment fund. The recent fund closing follows the establishment of Concord’s Nashville office, and the addition of Atlantic Health System’s Brian Gragnolati as executive partner and Derek Schmidt and Erik Larsen as managing directors.
